PHP
AMGN icon

Parkman Healthcare Partners’s Amgen AMGN Stock Holding History

Parkman Healthcare Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,524
Closed -$17.7M – 100
2023
Q4 		$17.7M Buy
61,524
+41,524
+208% +$11.3M 2.5% 11
2023
Q3 		$5.38M Buy
+20,000
New +$4.99M 0.98% 33
2021
Q4 		– Sell
-20,000
Closed -$4.25M – 85
2021
Q3 		$4.25M Buy
+20,000
New +$4.6M 1.08% 30
2021
Q2 		– Sell
-45,059
Closed -$11.2M – 83
2021
Q1 		$11.2M Buy
+45,059
New +$10.8M 2.6% 12

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkman Healthcare Partners's AMGN Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of Amgen (AMGN) in Q1 2024, closing a stake of 61,524 shares — an estimated $17.7M sold.

Parkman Healthcare Partners first reported a position in AMGN in Q1 2021 and held it in 4 quarters. The position peaked at $17.7M in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Parkman Healthcare Partners reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 61,524 Amgen shares in Q1 2024, an estimated $17.7M.
  • Parkman Healthcare Partners first reported a position in Amgen in Q1 2021 and held it in 4 quarters.
  • Parkman Healthcare Partners's Amgen position peaked at $17.7M in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.